Tapan K. Bhattacharyya
No ORCID on file
· 1 paper in corpus
article
2010
Background: Ormeloxifene, a third generation selective estrogen receptor modulator, has been claimed to ameliorate symptoms of DUB. This study was undertaken to compare the efficacy of ormeloxifene and norethisterone.